Health Condition 1: B359- Dermatophytosis, unspecified Health Condition 2: L088- Other specified local infections of the skin and subcutaneous tissue Health Condition 3: null- tinea infection
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients clinically diagnosed with tinea infection (tinea pedis, cruris, corporis, capitis, barbae, mannum ,ungium.). Patients of both sexes. Patients between 18 years to 60 years of age. Ability to understand and sign the informed consent. Direct microscopic examination of the skin scraping which shows positive for dermatophytes.
Exclusion criteria
Exclusion criteria: Pregnant women or nursing mother. Use of other topical or oral antifungal drugs, immunosuppressive drugs, anthelmintic drugs either currently or during the 2 weeks preceding initiation of drug trial. Allergy or hypersensitivity of any component of the drug. Clinical case of Eczema, Psoriasis, Lichen planus, Pityriasis versicolor, Drug induced eruptions, Urticaria, Intertrigo. Diabetic patients.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| skin scrapping test negative for dermatophytesTimepoint: skin scrapping test negative for dermatophytes | — |
Secondary
| Measure | Time frame |
|---|---|
| relief from itching,burning sensation, ooze, vesicles, putules, hyperkeratosis etcTimepoint: 45 days | — |
Countries
India
Contacts
NATIONAL INSTITUTE OF SIDDHA